Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA5 | P22460 | 7/20 | 0.77 |
| ▸ | CYP2D6 | P10635 | 6/20 | 0.77 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.77 |
| ▸ | CYP2C19 | P33261 | 6/20 | 0.77 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.77 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.77 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.77 |
| ▸ | KCNE1 | P15382 | 2/20 | 0.77 |
| ▸ | MAOB | P27338 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | MC4R | P32245 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11587497 | 1.00 | KCNA5 (0.77) | KCNA5CYP2D6CYP3A4CYP2C19CYP1A2 | |
| SCHEMBL10125332 | 0.98 | KCNA5 (0.76) | KCNA5CYP2D6CYP3A4CYP2C19CYP1A2 | |
| SCHEMBL16226493 | 0.87 | KCNA5 (1.00) | KCNA5CYP2D6CYP3A4CYP2C19CYP1A2 | |
| SCHEMBL16227210 | 0.87 | KCNA5 (1.00) | KCNA5CYP2D6CYP3A4CYP2C19CYP1A2 | |
| SCHEMBL16227209 | 0.87 | KCNA5 (1.00) | KCNA5CYP2D6CYP3A4CYP2C19CYP1A2 | |
| SCHEMBL9365972 | 0.87 | KCNA5 (0.69) | KCNA5CYP2D6CYP3A4CYP2C19CYP1A2 | |
| SCHEMBL11118177 | 0.85 | CYP2C19 (0.71) | KCNA5CYP2D6CYP3A4CYP2C19CYP1A2 | |
| SCHEMBL14269710 | 0.84 | KCNA5 (0.73) | KCNA5CYP2D6CYP3A4CYP2C19CYP1A2 | |
| SCHEMBL18901676 | 0.82 | CYP2C19 (0.70) | KCNA5CYP2D6CYP3A4CYP2C19CYP1A2 | |
| SCHEMBL12587705 | 0.82 | KCNA5 (0.80) | KCNA5CYP2D6CYP3A4CYP2C19CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9765087-B2 | Benzimidazole derivatives | ENANTA PHARMACEUTICALS, INC. (US) | 2017-09-19 | — | — | US | disclosed |
| US-8101643-B2 | Benzimidazole derivatives | ENANTA PHARMACEUTICALS, INC. (US) | 2012-01-24 | — | — | US | disclosed |
| US-20100266543-A1 | LINKED DIBENZIMIDAZOLE ANTIVIRALS | ENANTA PHARMACEUTICALS, INC. | 2010-10-21 | — | — | US | disclosed |
| US-20100233122-A1 | NOVEL BENZIMIDAZOLE DERIVATIVES | ENANTA PHARMACEUTICALS, INC. | 2010-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100233122-A1 | NOVEL BENZIMIDAZOLE DERIVATIVES | EIF2AK2, ZC3HAV1, HAVCR2 | KCNA5 3425/4885CYP2D6 497/4885CYP3A4 56/4885 |
| US-20100266543-A1 | LINKED DIBENZIMIDAZOLE ANTIVIRALS | EIF2AK2, ZC3HAV1, NSUN2 | KCNA5 4179/4885CYP2D6 309/4885CYP3A4 87/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.